HCPCS Level IIdrugActive
J9289
Inj nivolumab 2 mg hyaluron
BETOS: O1D
Effective: 2025-07-01
Description
Injection, nivolumab, 2 mg and hyaluronidase-nvhy
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Opdivo Qvantig
Manufacturer
E.R. Squibb & Sons, L.L.C.
HCPCS Dosage
2 MG
Billing Units
300.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.